These 3 Stocks Are Absurdly Overvalued Right Now_老虎社区_美港股上老虎

These 3 Stocks Are Absurdly Overvalued Right Now

Motley Fool2021-04-09

One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

操作要有逻辑
·2021-04-12
风险提示很好
回复
点赞
举报
justinC
·2021-04-12
?
回复
点赞
举报
boonhup
·2021-04-12
Please like and comment thanks!
回复
2
举报
收起
- Acella:
  😀
  2021-04-12
  回复
  举报
- eeez:
  OK
  2021-04-12
  回复
  举报
CheeMang
·2021-04-11
Nice. Pls comment
回复
1
举报
收起
- boonhup:
  done
  2021-04-12
  回复
  举报
SimonGoh
·2021-04-11
[得意]
回复
点赞
举报
收起
- CheeMang:
  Nice
  2021-04-11
  回复
  举报
JFK
·2021-04-11
Pls like and comment.
回复
2
举报
收起
- boonhup:
  done
  2021-04-12
  回复
  举报
okkar
·2021-04-11
Sell sell sell!
回复
2
举报
收起
- Jon000:
  Loke n reply pls
  2021-04-11
  回复
  举报
- okkar:
  Liked!
  2021-04-11
  回复
  举报
MaddyLIM
·2021-04-11
Subjective!
回复
3
举报
收起
- Jon000:
  Like N reply pla
  2021-04-11
  回复
  举报
Sebastianng
·2021-04-11
Roger
回复
2
举报
andrew123
·2021-04-10
Risk reward is to dtay out of this stk
回复
5
举报
dontlose
·2021-04-10
Agree.
回复
2
举报
Ichua
·2021-04-10
Carnival to the moon
回复
3
举报
kuehlapis
·2021-04-10
good pointers
回复
2
举报
Arch_Mints_
·2021-04-09
Just want to make you sell. Something big isabout to happen!
回复
1
举报
Peisim
·2021-04-09
Hmm?
回复
1
举报
Yoxin
·2021-04-09
Ok
回复
3
举报
收起
- Yoxin:
  Ok
  2021-04-09
  回复
  举报
valueTrader
·2021-04-09
Where is$GameStop(GME)$?
回复
1
举报
收起
- Frank838:
  Haha
  2021-04-09
  回复
  举报
Jacoble
·2021-04-09
Wow comment and like
回复
点赞
举报
Dennishyh
·2021-04-09
Noted
回复
点赞
举报
Chiephang
·2021-04-09
Hmm
回复
1
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2126081296?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-04-09 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2126081296","market":"us","top_or_hot":-1,"title":"These 3 Stocks Are Absurdly Overvalued Right Now","media":"Motley Fool","content":"<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CCL","symbol_name":"嘉年华邮轮","start_time":0,"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","article_id":"2126081296","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","pubTimestamp":1617974640,"columns":[],"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CCL":"嘉年华邮轮","GDRX":"GoodRx Holdings, Inc.","TWTR":"Twitter"},"translate_title":"这三只股票目前被高估得离谱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CCL":0.9,"GDRX":0.9,"TWTR":0.9},"content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":342715234,"gmtCreate":1618242105828,"gmtModify":1618242105828,"author":{"id":"3495752843397571","authorId":"3495752843397571","name":"操作要有逻辑","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3495752843397571","idStr":"3495752843397571"},"htmlText":"风险提示很好","listText":"风险提示很好","text":"风险提示很好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342715234","repostId":2126081296,"repostType":2,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":342384017,"gmtCreate":1618185395839,"gmtModify":1634294613740,"author":{"id":"3580980349710552","authorId":"3580980349710552","name":"justinC","avatar":"https://static.tigerbbs.com/b1df8f1b7bfcecfea836a18bee080563","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580980349710552","idStr":"3580980349710552"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342384017","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":342306332,"gmtCreate":1618180815826,"gmtModify":1634294647023,"author":{"id":"3570863489388697","authorId":"3570863489388697","name":"boonhup","avatar":"https://static.tigerbbs.com/aefb0b8716445957d6db1796c7bc4dd4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570863489388697","idStr":"3570863489388697"},"htmlText":"Please like and comment thanks!","listText":"Please like and comment thanks!","text":"Please like and comment thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/342306332","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4012467,"gmtCreate":1618195453365,"gmtModify":1635740431308,"authorId":3563150446821026,"author":{"id":3563150446821026,"idStr":"3563150446821026","authorId":3563150446821026,"name":"Acella","avatar":"https://static.tigerbbs.com/2712c4bb0bfbec4d2773e012189db3bc","vip":1,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342306332,"type":1,"supId":0,"prevId":0,"content":"😀","text":"😀","html":"😀"},{"id":4010985,"gmtCreate":1618186925246,"gmtModify":1618186925246,"authorId":3570813663502369,"author":{"id":3570813663502369,"idStr":"3570813663502369","authorId":3570813663502369,"name":"eeez","avatar":"https://static.tigerbbs.com/3e4f974ced53f13a2b714d56018e7b43","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342306332,"type":1,"supId":0,"prevId":0,"content":"OK","text":"OK","html":"OK"}],"langContent":"EN"},{"id":342965633,"gmtCreate":1618154747322,"gmtModify":1634294683834,"author":{"id":"3573033813970769","authorId":"3573033813970769","name":"CheeMang","avatar":"https://static.tigerbbs.com/97f355a1d36ee0fb7321de6482b9764f","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3573033813970769","idStr":"3573033813970769"},"htmlText":"Nice. Pls comment","listText":"Nice. Pls comment","text":"Nice. Pls comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342965633","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4010040,"gmtCreate":1618180795941,"gmtModify":1635740622664,"authorId":3570863489388697,"author":{"id":3570863489388697,"idStr":"3570863489388697","authorId":3570863489388697,"name":"boonhup","avatar":"https://static.tigerbbs.com/aefb0b8716445957d6db1796c7bc4dd4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342965633,"type":1,"supId":0,"prevId":0,"content":"<u>done</u>","text":"<u>done</u>","html":"<u>done</u>"}],"langContent":"EN"},{"id":342965078,"gmtCreate":1618154659494,"gmtModify":1634294684075,"author":{"id":"3576306005094300","authorId":"3576306005094300","name":"SimonGoh","avatar":"https://static.tigerbbs.com/73b898c8aede2bc74299e222da0c4a75","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576306005094300","idStr":"3576306005094300"},"htmlText":"[得意]&nbsp;","listText":"[得意]&nbsp;","text":"[得意]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342965078","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4009467,"gmtCreate":1618154761229,"gmtModify":1635740661267,"authorId":3573033813970769,"author":{"id":3573033813970769,"idStr":"3573033813970769","authorId":3573033813970769,"name":"CheeMang","avatar":"https://static.tigerbbs.com/97f355a1d36ee0fb7321de6482b9764f","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342965078,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"CN"},{"id":342042609,"gmtCreate":1618138231501,"gmtModify":1634294732596,"author":{"id":"3567221235003553","authorId":"3567221235003553","name":"JFK","avatar":"https://static.tigerbbs.com/d8cdaf8b81ae245f2f2ea5ff303a6722","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3567221235003553","idStr":"3567221235003553"},"htmlText":"Pls like and comment.&nbsp;","listText":"Pls like and comment.&nbsp;","text":"Pls like and comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342042609","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4010039,"gmtCreate":1618180787737,"gmtModify":1635740622772,"authorId":3570863489388697,"author":{"id":3570863489388697,"idStr":"3570863489388697","authorId":3570863489388697,"name":"boonhup","avatar":"https://static.tigerbbs.com/aefb0b8716445957d6db1796c7bc4dd4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342042609,"type":1,"supId":0,"prevId":0,"content":"<u>done</u>","text":"<u>done</u>","html":"<u>done</u>"}],"langContent":"EN"},{"id":342018673,"gmtCreate":1618126255092,"gmtModify":1634294771966,"author":{"id":"3580969894464089","authorId":"3580969894464089","name":"okkar","avatar":"https://static.tigerbbs.com/5284953eb6a2c6608eb0336ea3795f46","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3580969894464089","idStr":"3580969894464089"},"htmlText":"Sell sell sell!","listText":"Sell sell sell!","text":"Sell sell sell!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/342018673","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4008076,"gmtCreate":1618130108550,"gmtModify":1635740763031,"authorId":3574488501440064,"author":{"id":3574488501440064,"idStr":"3574488501440064","authorId":3574488501440064,"name":"Jon000","avatar":"https://static.tigerbbs.com/31d8b0b435484918436ab24cf32410e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342018673,"type":1,"supId":0,"prevId":0,"content":"Loke n reply pls","text":"Loke n reply pls","html":"Loke n reply pls"},{"id":4008835,"gmtCreate":1618145579560,"gmtModify":1635740707821,"authorId":3580969894464089,"author":{"id":3580969894464089,"idStr":"3580969894464089","authorId":3580969894464089,"name":"okkar","avatar":"https://static.tigerbbs.com/5284953eb6a2c6608eb0336ea3795f46","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342018673,"type":1,"supId":0,"prevId":0,"content":"Liked!","text":"Liked!","html":"Liked!"}],"langContent":"EN"},{"id":342098940,"gmtCreate":1618122853280,"gmtModify":1634294786358,"author":{"id":"3576843963312863","authorId":"3576843963312863","name":"MaddyLIM","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576843963312863","idStr":"3576843963312863"},"htmlText":"Subjective!","listText":"Subjective!","text":"Subjective!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342098940","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4008077,"gmtCreate":1618130116236,"gmtModify":1635740762920,"authorId":3574488501440064,"author":{"id":3574488501440064,"idStr":"3574488501440064","authorId":3574488501440064,"name":"Jon000","avatar":"https://static.tigerbbs.com/31d8b0b435484918436ab24cf32410e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":342098940,"type":1,"supId":0,"prevId":0,"content":"Like N reply pla","text":"Like N reply pla","html":"Like N reply pla"}],"langContent":"EN"},{"id":346784399,"gmtCreate":1618113958811,"gmtModify":1634294837152,"author":{"id":"3554842736287005","authorId":"3554842736287005","name":"Sebastianng","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3554842736287005","idStr":"3554842736287005"},"htmlText":"Roger","listText":"Roger","text":"Roger","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346784399","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346534475,"gmtCreate":1618065965697,"gmtModify":1634295010434,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3576260758860416","idStr":"3576260758860416"},"htmlText":"Risk reward is to dtay out of this stk","listText":"Risk reward is to dtay out of this stk","text":"Risk reward is to dtay out of this stk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346534475","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346225396,"gmtCreate":1618052802715,"gmtModify":1634295052293,"author":{"id":"3578390540207500","authorId":"3578390540207500","name":"dontlose","avatar":"https://static.tigerbbs.com/83dae59fdfe891a662b9f6cf00aeefbb","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3578390540207500","idStr":"3578390540207500"},"htmlText":"Agree.&nbsp;","listText":"Agree.&nbsp;","text":"Agree.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346225396","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346846093,"gmtCreate":1618024633012,"gmtModify":1634295168689,"author":{"id":"3554848762875033","authorId":"3554848762875033","name":"Ichua","avatar":"https://static.tigerbbs.com/175ebc8e659de3f491645e9236066d54","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3554848762875033","idStr":"3554848762875033"},"htmlText":"Carnival to the moon","listText":"Carnival to the moon","text":"Carnival to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346846093","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346372484,"gmtCreate":1618009818948,"gmtModify":1634295299699,"author":{"id":"3574029017802033","authorId":"3574029017802033","name":"kuehlapis","avatar":"https://static.tigerbbs.com/732ffeea71fc0732b84f029cc0e8263e","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3574029017802033","idStr":"3574029017802033"},"htmlText":"good pointers","listText":"good pointers","text":"good pointers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346372484","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346964220,"gmtCreate":1617981174560,"gmtModify":1634295380963,"author":{"id":"3576121666701741","authorId":"3576121666701741","name":"Arch_Mints_","avatar":"https://static.tigerbbs.com/c24a88acc5f19ddae6f47bbaa50a5344","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3576121666701741","idStr":"3576121666701741"},"htmlText":"Just want to make you sell. Something big isabout to happen!","listText":"Just want to make you sell. Something big isabout to happen!","text":"Just want to make you sell. Something big isabout to happen!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346964220","repostId":2126081296,"repostType":2,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346963386,"gmtCreate":1617980751845,"gmtModify":1631891610074,"author":{"id":"3573463420389142","authorId":"3573463420389142","name":"Peisim","avatar":"https://static.tigerbbs.com/174e40f39b76c8ddc43221a30b624d87","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573463420389142","idStr":"3573463420389142"},"htmlText":"Hmm?","listText":"Hmm?","text":"Hmm?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346963386","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346075135,"gmtCreate":1617977531927,"gmtModify":1634295413734,"author":{"id":"3571470148893542","authorId":"3571470148893542","name":"Yoxin","avatar":"https://static.tigerbbs.com/3184024bf3d660bd49cc2158ebd27b3f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571470148893542","idStr":"3571470148893542"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346075135","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3996757,"gmtCreate":1617977543512,"gmtModify":1635741546232,"authorId":3571470148893542,"author":{"id":3571470148893542,"idStr":"3571470148893542","authorId":3571470148893542,"name":"Yoxin","avatar":"https://static.tigerbbs.com/3184024bf3d660bd49cc2158ebd27b3f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":346075135,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":346057344,"gmtCreate":1617976702688,"gmtModify":1634295423260,"author":{"id":"3576118384681891","authorId":"3576118384681891","name":"valueTrader","avatar":"https://static.tigerbbs.com/9b20c817213be1647e2dee23f5d62e0d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576118384681891","idStr":"3576118384681891"},"htmlText":"Where is<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>?","listText":"Where is<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>?","text":"Where is$GameStop(GME)$?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346057344","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3997483,"gmtCreate":1617981791392,"gmtModify":1635741507688,"authorId":3557658553162330,"author":{"id":3557658553162330,"idStr":"3557658553162330","authorId":3557658553162330,"name":"Frank838","avatar":"https://static.tigerbbs.com/0a37502bcae3223514fa473cba9087be","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":346057344,"type":1,"supId":0,"prevId":0,"content":"Haha","text":"Haha","html":"Haha"}],"langContent":"EN"},{"id":346028355,"gmtCreate":1617975937477,"gmtModify":1634295430365,"author":{"id":"3578607602231616","authorId":"3578607602231616","name":"Jacoble","avatar":"https://static.tigerbbs.com/19e355281937c20e926e5a42ed3b6313","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578607602231616","idStr":"3578607602231616"},"htmlText":"Wow comment and like","listText":"Wow comment and like","text":"Wow comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346028355","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346029217,"gmtCreate":1617975773439,"gmtModify":1634295431543,"author":{"id":"3579224673007813","authorId":"3579224673007813","name":"Dennishyh","avatar":"https://static.tigerbbs.com/79de7417eb609458d6cb6e72e515dadb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579224673007813","idStr":"3579224673007813"},"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346029217","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":346063671,"gmtCreate":1617975394793,"gmtModify":1634295435623,"author":{"id":"3561985126714462","authorId":"3561985126714462","name":"Chiephang","avatar":"https://static.tigerbbs.com/946bb9a277021b41602c10a2e48fa31b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3561985126714462","idStr":"3561985126714462"},"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346063671","repostId":2126081296,"repostType":4,"repost":{"id":"2126081296","kind":"highlight","pubTimestamp":1617974640,"share":"https://www.laohu8.com/m/news/2126081296?lang=&edition=full","pubTime":"2021-04-09 21:24","market":"us","language":"en","title":"These 3 Stocks Are Absurdly Overvalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2126081296","media":"Motley Fool","summary":"The best buy on this list trades over a ridiculous 60 times its future earnings.","content":"<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.</p>\n<p>Ignoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are <b>GoodRx</b> (NASDAQ:GDRX), <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a>&nbsp;</b>(NYSE:TWTR), and <b>Carnival&nbsp;</b>(NYSE:CCL).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/979124c02285d2499c41044704d715c9\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images</span></p>\n<h2>1. GoodRx</h2>\n<p>GoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.</p>\n<p>GoodRx's lack of an edge is especially concerning given <a href=\"https://laohu8.com/S/AONE\">one</a> of its competitors may end up being <b>Amazon </b>(NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.</p>\n<p>And GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&amp;A) expenses. Expenses of $716.6 million&nbsp;represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.</p>\n<p>GoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the <b>S&amp;P 500&nbsp;</b>(which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.</p>\n<h2>2. Twitter</h2>\n<p>Another stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.</p>\n<p>While Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.</p>\n<p>Although it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.</p>\n<h2>3. Carnival</h2>\n<p>Carnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.</p>\n<p>On April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.</p>\n<p>However, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.</p>\n<p>Cash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.</p>\n<p>Carnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.</p>\n<p>There simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Are Absurdly Overvalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Are Absurdly Overvalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GDRX":"GoodRx Holdings, Inc.","CCL":"嘉年华邮轮","TWTR":"Twitter"},"source_url":"https://www.fool.com/investing/2021/04/09/these-3-stocks-are-absurdly-overvalued-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126081296","content_text":"One of the dangers of investing right now is that there are many high-priced stocks out there. Even though a business may be doing well, paying a high price to own a piece of it may not be a good idea, as it could limit your returns -- or worse, you could actually incur a loss on it.\nIgnoring earnings multiples and valuations can be a surefire way to put your portfolio in harm's way. And three stocks that are incredibly overvalued right now and that you should be extremely careful with are GoodRx (NASDAQ:GDRX), Twitter (NYSE:TWTR), and Carnival (NYSE:CCL).\nImage source: Getty Images\n1. GoodRx\nGoodRx's business makes it easier for consumers to buy prescriptions at lower prices. But the problem is that the company doesn't have a strong competitive advantage that can keep rivals at bay.\nGoodRx's lack of an edge is especially concerning given one of its competitors may end up being Amazon (NASDAQ:AMZN). The tech giant is going deeper into healthcare, recently launching telehealth services in addition to its pharmacy business. With its deep pockets, Amazon could undercut competitors and make it hard for GoodRx to generate long-term sales growth. Amazon advertises that Prime members who pay without insurance can save up to 80% on medication through Amazon Pharmacy.\nAnd GoodRx already has enough problems of its own to worry about, incurring losses in each of its last two quarters. Although it grew its sales in 2020 by 41.9% to $550.7 million, it is spending a staggering amount of money on selling, general, and administrative (SG&A) expenses. Expenses of $716.6 million represented 130% of revenue. And if there is an increase in competition, that percentage could climb even higher.\nGoodRx's forward price-to-earnings (P/E) multiple of more than 110 is obscene, and puts it at a high valuation regardless of which industry you are investing in. Even though the stock is down 19% over the past year and has underperformed the S&P 500 (which is up 24%), I wouldn't be surprised to see its shares fall even further, as there are still many question marks in GoodRx's future.\n2. Twitter\nAnother stock trading at a hefty premium is Twitter. Its forward P/E of 74 is now even higher than Amazon's multiple, which is just over 69. And fiscal year 2020's sales of $3.7 billion weren't all that impressive for the social media company, as its top line grew by just 7.4% from 2019 -- hardly the numbers you would expect when you are paying such a steep premium for a growth stock. And to make matters worse, its operating expenses grew at an even higher rate of 19.3%.\nWhile Twitter may think adding \"Super Follows\" to charge followers for content and moving more toward a subscription model will help its bottom line, I'm not convinced it will work in the long term, as it could turn off existing users. It is also a move that shows some desperation, and is perhaps a sign that the company isn't sure ad revenue alone will be enough to make its business profitable over the long haul.\nAlthough it has come off its recent highs, the stock is still up a mindboggling 74% over the past 12 months, and it could be due for a big correction if the markets crash this year.\n3. Carnival\nCarnival's stock has soared 159% in 12 months, and sending this company to the top of this list in terms of share price performance. By the look of the stock chart, you would have to assume that the cruise ship operator is doing exceptionally well. But the reality is that this is still a risky investment despite the ongoing vaccine rollouts.\nOn April 7, Carnival reported that its net loss for the first quarter of 2021 (period ending Feb. 28) was a mammoth $1.97 billion, more than double the $781 million loss it incurred during the same period a year ago. The company is optimistic; it noted that for Q1, its booking volumes were 90% higher than in the previous period.\nHowever, the deposits it collected this past quarter effectively offset the effect that refunds had on its business. And many of its bookings are beyond this year, as just $0.7 billion of the $1.8 billion Carnival has in current customer deposits are for trips in 2021.\nCash is also still a big concern. In February, Carnival issued $3.5 billion in senior unsecured notes and completed an equity offering for $1 billion. Although the company says its monthly cash burn rate has been \"better than expected,\" at $500 million per month, that is still an extremely high amount. With $11.5 billion of cash and short-term investments, Carnival isn't in danger of running out of money anytime soon -- but the threat of more shareholder dilution is going to remain there for the foreseeable future.\nCarnival's stock doesn't have a forward P/E multiple because it's not likely the company will be profitable anytime soon, making its incredible rise in value even that much more ridiculous. With COVID-19 outbreaks on cruises last year generating lots of attention, many customers may not be all that eager to get back on cruise ships. And while some may want to use up their credits or speculate on 2022, there is no guarantee future sailings will go as expected.\nThere simply isn't much of a reason to invest in this business right now, and it's likely just speculation that is driving the rise in Carnival's share price. This is a stock I would stay far away from. If new variants of COVID-19 prove to be a problem and case numbers continue climbing despite vaccinations, that could lead to a more negative outlook for the business and lead to an aggressive sell-off.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":46,"commentSize":21,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}